Kasinger James R.'s Form 4 filing
CRISPR Therapeutics AG (CRSP) · filed Feb 19, 2025
- Accession no.
- 0000950170-25-023386
- Filed
- Feb 19, 2025
- Trade date
- Feb 16-19, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $619.5K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kasinger James R.CIK 0001708172 | Officer (General Counsel and Secretary) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2025 | Common Shares | MOption exerciseAcquired | +20,000 | – | – | 82,597 | Direct | |
| Feb 18, 2025 | Common Shares | SSaleDisposed | −9,595 | $53.85 | −$516,690.75 | 73,002 | Direct | |
| Feb 18, 2025 | Common Shares | MOption exerciseAcquired | +3,825 | – | – | 76,827 | Direct | |
| Feb 19, 2025 | Common Shares | SSaleDisposed | −1,947 | $52.80 | −$102,801.6 | 74,880 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2025 | Common Shares | MOption exerciseDisposed | −20,000 | – | – | 0 | Direct | |
| Feb 18, 2025 | Common Shares | MOption exerciseDisposed | −3,825 | – | – | 3,825 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.